Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK21542 for Pruritus in Liver Disease
NCT04999787Phase 2Completed
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Sep 2021
- Primary completion
- Aug 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of hsk21542 in pruritus (3 arms), sponsored by Haisco Pharmaceutical Group Co., Ltd. Primary endpoints: Changes in daily Worst Itching Intensity Numerical Rating Scale scores from baseline, Proportion of subjects whose daily WI-NRS scores improve by >= 3 points and >= 4 points and 4 more. Started Sep 2021; status: completed.
02
Drugs
hsk21542
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT04999787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04999787.